Giant Cell Arteritis - Optimization of Diagnostics
NCT05248906 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 110
Last updated 2025-04-02
Summary
Giant cell arteritis - Optimization of diagnostics
Conditions
- Giant Cell Arteritis
Interventions
- DIAGNOSTIC_TEST
-
Giant cell arteritis
Ultrasound 18F-fluorodeoxyglucose (18F-FDG) Positron Emission Tomography Temporal artery biopsy
Sponsors & Collaborators
-
Rigshospitalet, Denmark
lead OTHER
Principal Investigators
-
Steffen Hamann, MD, PhD,FEBO · Rigshospitalet, Denmark
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-03-19
- Primary Completion
- 2024-01-01
- Completion
- 2024-01-01
Countries
- Denmark
Study Locations
More Related Trials
-
Non-Invasive Assessment of Atherosclerosis in Patients With CGD and Other Disorders of the Immune System
NCT01063309 ·Status: COMPLETED
-
Role of NGAL in Vitiligo
NCT05290077 ·Status: UNKNOWN ·Phase: NA
-
Evaluation Study of RDTs Detecting Antibodies Against HCV
NCT04033887 ·Status: COMPLETED
-
Repeat Immunoadsorption Post Covid ME/CFS
NCT05629988 ·Status: COMPLETED
-
Study of the C5a/C5aR1 Axis in IgG4-associated Disease: a Potential Therapeutic Target
NCT06270524 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Discovery and Validation of Proteogenomic Biomarker Panels in Liver Transplant Recipients
NCT01672164 ·Status: COMPLETED
-
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
NCT06605378 ·Status: RECRUITING
-
Whole Blood Biospecimen Collection for Subjects With Chronic Granulomatous Disease (CGD)
NCT05915897 ·Status: TERMINATED
-
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis
NCT00160940 ·Status: UNKNOWN
-
Bartonella in Liver Transplant Patients
NCT02595710 ·Status: COMPLETED
-
COVID-19 Antibodies Among Healthcare Workers
NCT04425889 ·Status: COMPLETED
-
Long Term Outcomes in COVID-19 Patients Recruited in the CORIST Project
NCT04907890 ·Status: WITHDRAWN
-
COVID-19 in Baselland: Investigation and Validation of Serological Diagnostic Assays and Epidemiological Study of Sars-CoV-2 Specific Antibody Responses
NCT04483908 ·Status: COMPLETED
-
Multicenter Study Evaluating the Performance of the Assay of Anti-hinge Region Antibodies in the Diagnosis of Progressive Forms of IgA Nephropathy
NCT02526966 ·Status: COMPLETED ·Phase: NA
-
A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease
NCT06587828 ·Status: RECRUITING
-
Biomarker for Gaucher Disease: BioGaucher (BioGaucher)
NCT01331642 ·Status: WITHDRAWN
-
Surveillance for Early Liver Injuries Caused by Zhuanggu Guanjie Pill
NCT03060252 ·Status: UNKNOWN
-
Pathogenesis of Glomerulosclerosis
NCT00001392 ·Status: COMPLETED
-
Prognostic Value of Anti-Ro52 Antibodies in Connective Tissue Diseases (a-Ro52)
NCT03565601 ·Status: UNKNOWN
-
Proteogenomic Monitoring and Assessment of Liver Transplant Recipients
NCT01644903 ·Status: RECRUITING
-
A Natural History Study to Assess the Clinical Outcomes of Patients With Complement Factor I Deficiency-Mediated Disease
NCT05095623 ·Status: TERMINATED
-
Antibody Response Against SARS-CoV-2 in Dialysis Patients During COVID-19
NCT04367714 ·Status: UNKNOWN
-
Neutralizing Antibody Level After COVID-19 Vaccination
NCT05083026 ·Status: RECRUITING
-
Circulating Anti-Beta2-glycoprotein Antibodies and Endothelial Dysfunction
NCT01822990 ·Status: COMPLETED
-
Characterization of the Immunometabolic Signature in Long COVID-19.
NCT05758480 ·Status: COMPLETED ·Phase: NA